The mouse mahoganoid coat color mutation disrupts a novel C3HC4 RING domain protein

Journal of Clinical Investigation

Volumn 110, Issue 10, 2002, Pages 1449-1459

  Phan, Loan K ^a   Lin, Feng ^a   LeDuc, Charles A ^a   Chung, Wendy K ^a,b   Leibel, Rudolph L ^a,b  

^a Columbia University ^*  (United States)

^b Columbia University Irving Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; UBIQUITIN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; BODY WEIGHT; C3HC4 RING GENE; CONTROLLED STUDY; DOSE RESPONSE; EPISTASIS; GENE; GENE MUTATION; GENE OVEREXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; HOMEOSTASIS; HYPOTHALAMUS; MAHOGANOID GENE; MEASUREMENT; MOUSE; MOUSE STRAIN; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; SKIN COLOR;

EID: 0036854790     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0216131     Document Type: Article

References (39)

1. Leibel, R.L., Chung, W.K., and Chua, S.C. 1997. The molecular genetics of rodent single gene obesities. J. Biol. Chem. 272:31937-31940.
2. Bultman, S.J., Michaud, E.J., and Wovchik, R.P. 1992. Molecular characterization of the mouse agouti locus. Cell. 71:1195-1204.
3. Miller, M.W., et al. 1993. Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev. 7:454-467.
4. Michaud, E.J., et al. 1994. A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation. Proc. Natl. Acad. Sci. USA. 91:2562-2566.
5. Wolff, G.L., Galbraith, D.B., Domon, O.E., and Row, J.M. 1978. Phaeomelanin synthesis and obesity in mice. Interaction of the viable yellow (Avy) and sombre (eso) mutations. J. Hered. 69:295-298.
6. Nijenhuis, W., Oosterom, J., and Adan, R. 2001. AgRP(83-132) acts as an inverse agonist on the human melanocortin-4 receptor. Mol. Endocrinol. 15:164-171.
7. Haskell-Luevano, C., and Monck, E.K. 2001. Agouti-related protein functions as an inverse agonist as a constitutively active brain melanocortin-4 receptor. Regul. Pept. 99:1-7.
8. Ollmann, M.M. 1997. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science. 278:135-138.
9. Nagle, D.L. et al. 1999. The mahogany protein is a receptor involved in suppression of obesity. Nature. 398:148-152.
10. Gunn, T.M., et al. 1999. The mouse mahogany locus encodes a transmembrane form of human attractin. Nature. 398:152-156.
11. Dinulescu, D.M., et al. 1998. Mahogany (mg) stimulates feeding and increases basal metabolic rate independent of its suppression of agouti. Proc. Natl. Acad. Sci. USA. 95:12707-12712.
12. Gunn, T. 2001. Molecular and phenotypic analysis of attractin mutant mice. Genetics. 158:1683-1695.
13. Kuramoto, T., Kitada, K., Inui, I., Sasaki, Y., and Ito, K. 2001. Attractin/Mahogany/Zitter plays a critical role in myelination of the central nervous system. Proc. Natl. Acad. Sci. USA. 98:559-564.
14. He, L., et al. 2001. A biochemical Function for attractin in agouti-induced pigmentation and obesity. Nat. Genet. 27:40-47.
15. Lane, P.W. 1960. New mutants. Mouse News Letter. 22:35.
16. Lane, P.W., and Green, M.C. 1960. Mahogany, a recessive color mutation in linkage group V of the mouse. J. Hered. 51:228-230.
17. Miller, K.A., et al. 1997. Genetic studies of the mouse mutations mahogany and mahoganoid. Genetics. 146:1407-1415.
18. Green, M.C. 1989. Genetic Variants and Strains of the Laboratory Mouse. Oxford University Press. Oxford, United Kingdom. 1-876.
19. Roderick, T., Davisson, M., and Lane, P. 1976. Chromosome 16 and mahoganoid md. Mouse News Letter. 55:18.
20. Chung, W.K., et al. 1997. Exonic and intronic sequence variation in the human leptin receptor gene (LEPR). Diabetes. 46:1509-1511.
21. Sambrook, J., Fritsch, E.F., and Maniatis, T. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press. Plainview, New York, USA. 9.31-9.57.
22. Pfaffl, M.W., et al. 2002. Real-time RT-PCR quantification of insulin-like growth factor (IGF)-1, IGF-1 receptor, IGF-2, IGF-2 receptor, insulin receptor, growth hormone receptor, IGF-binding proteins 1,2 and 3 in the bovine species. Domest. Anim. Endocrinol. 22:91-102.
23. Roderick, T., Donahue, L., Samples, R., Kim, J., and Naggert, J. 2001. Mice with mutations in the mahogany gene atrn have cerebral spongiform changes. J. Neuropathol. Exp. Neurol. 60:724-730.
24. Venter, J.C., et al. 2001. The sequence of the human genome. Science. 291:1304-1351.
25. Lower, R. 1999. The pathogenic potential of endogenous retroviruses: Facts and fantasies. Trends in Microbiol. 7:350-356.
26. Nagase, T., et al. 1998. Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res. 5:31-39.
27. Bahary, N., et al. 1993. Microdissection of proximal mouse chromosome 6: Identification of RFLPs tightly linked to the ob mutation. Mamm. Genome. 4:511-515.
28. Yeo, G.S.H., Farooqi, I.S., Challis, B.G., Jackson, R.S., and O'Rahilly, S. 2000. The role of melanocortin signalling in the control of body weight: Evidence from human and murine genetic models. QJM. 93:7-14.
29. Seperack, P.K., Mercer, J.A., Strobel, M.C., Copeland, N.G., and Jenkins, N.A. 1995. Retroviral sequences located within an intron of the dilute gene alter dilute expression in a tissue-specific manner. EMBO J 14:2326-2332.
30. Palmiter, R.D., Erickson, J.C., Hollopeter, G., Baraban, S.C., and Schwartz, M.W. 1998. Life without neuropeptide Y. Recent Prog. Horm. Res. 53:163-199.
31. Saurin, A.J., Borden, K.L.B., Boddy, M.N., and Freemont, P.S. 1996. Does this have a familiar RING? Trends Biochem. Sci. 21:208-214.
32. Borden, K., and Freemont, P.S. 1996. The RING finger domain: A recent example of a sequence-structure family. Curr. Opin. Struct. Biol. 6:395-401.
33. Zheng, N., Wang, P., Jeffrey, P.D., and Pavletich, N.P. 2000. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102:533-539.
34. Joazeiro, C.A., and Weissman, A.M. 2000. RING finger proteins: Mediators of ubiquitin ligase activity. Cell. 102:549-552.
35. Conaway, R.C., Brower, C.S., and Conaway, J.W. 2002. Emerging roles of ubiquitin in transcription regulation. Science. 296:1254-1258.
36. Weissman, A.M. 2001. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2:169-178.
37. Layfield, R., Alban, A., Mayer, J.R., and Lowe, J. 2001. The ubiquitin protein catabolic disorders. Neuropathol. Appl. Neurobiol. 27:171-179.
38. Kwon, Y.T., Xia, Z., Davydov, I.V., Lecker, S.H., and Varshavsky, A. 2001. Construction and analysis of mouse strains lacking the ubiquiting ligase UBR1 (E3α) of the N-end rule pathway. Mol. Cell Biol. 21:8007-8021.
39. Francke, S., et al. 2001. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum. Mol. Genet. 10:2751-2765.